|
CEF23, Cytomegalovirus, CMV pp65 (123-131)
|
CEF23, CYTOMEGALOVIRUS, CMV PP65 (123-131)
|
|
|
Indolicidin
|
抗菌肽Indolicidin
|
140896-21-5
|
|
Influenza A NP (366-374) Strain A/NT/60/68
|
ALA-SER-ASN-GLU-MET-ASN-ASP-ALA-MET
|
|
|
Influenza A NP(366-374) Strain A/PR/8/35
|
ALA-SER-ASN-GLU-ASN-MET-GLU-THR-MET
|
132326-73-9
|
|
Influenza HA (110-119)
|
SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS
|
132031-50-6
|
|
Influenza HA (110-120)
|
SER-PHE-GLU-ARG-PHE-GLU-ILE-PHE-PRO-LYS-GLU
|
|
|
Influenza HA (126-138)
|
Influenza HA 126-138
|
207349-63-1
|
|
Influenza HA (204-212)
|
LEU-TYR-GLN-ASN-VAL-GLY-THR-TYR-VAL
|
|
|
Influenza HA (307-319)
|
PRO-LYS-TYR-VAL-LYS-GLN-ASN-THR-LEU-LYS-LEU-ALA-THR
|
528526-85-4
|
|
CEF25, Influenza Virus NP (44-52)
|
CEF25, INFLUENZA VIRUS NP (44-52)
|
|
|
CEF26, Influenza Virus NP (265-274)
|
CEF26, INFLUENZA VIRUS NP (265-274)
|
|
|
CEF27, Epstein-Barr Virus BRLF-1 lytic (148-156)
|
化合物CEF27, EPSTEIN-BARR VIRUS BRLF-1 LYTIC 1
|
254110-79-7
|
|
CEF28, Epstein-Barr Virus latent NA-3A (603-611)
|
CEF28, EPSTEIN-BARR VIRUS LATENT NA-3A (603-611)
|
|
|
CEF29, Epstein-Barr Virus latent NA-3B (416-424)
|
CEF29, EPSTEIN-BARR VIRUS LATENT NA-3B (416-424)
|
|
|
CEF3
|
SER-ILE-ILE-PRO-SER-GLY-PRO-LEU-LYS
|
199727-62-3
|
|
CEF30, Epstein-Barr Virus BRLF1 (134-142)
|
CEF30, EPSTEIN-BARR VIRUS BRLF1 (134-142)
|
|
|
CEF31, Epstein-Barr Virus latent NA-3A (379-387)
|
CEF31, EPSTEIN-BARR VIRUS LATENT NA-3A (379-387)
|
|
|
CEF32, Epstein-Barr Virus latent NA-3C (281-290)
|
CEF32, EPSTEIN-BARR VIRUS LATENT NA-3C (281-290)
|
|
|
CEF33, Cytomegalovirus, HCMV pp65
|
CEF33, CYTOMEGALOVIRUS, HCMV PP65
|
|
|
CEF4
|
ARG-VAL-LEU-SER-PHE-ILE-LYS-GLY-THR-LYS
|
199727-68-9
|
|
CEF5, Influenza Virus NP (91-99)
|
CEF5, INFLUENZA VIRUS NP (91-99)
|
|
|
CEF6
|
LEU-PRO-PHE-ASP-LYS-THR-THR-VAL-MET
|
913545-15-0
|
|
CEF7, Influenza Virus NP (380-388)
|
CEF7
|
147100-46-7
|
|
NA
|
CEF8,流感病毒NP 383-391
|
|
|
CEF9, Influenza Virus M1 128-135
|
CEF9, INFLUENZA VIRUS M1 128-135
|
|
|
CFP10 (71-85)
|
GLU-ILE-SER-THR-ASN-ILE-ARG-GLN-ALA-GLY-VAL-GLN-TYR-SER-ARG
|
646997-09-3
|
|
Chemerin-9 (149-157)
|
CHEMERIN-9 (149-157)
|
676367-27-4
|
|
CHRG01
|
CHRG01
|
|
|
CMV pp65 peptide
|
CMV PP65 PEPTIDE
|
|
|
Competence-Stimulating Peptide-2
|
感应信号肽
|
1174553-84-4
|
|
CSP1
|
苯酐(O-X氧化)催化剂
|
|
|
Drosocin
|
DROSOCIN
|
149924-99-2
|
|
Flagelin 22
|
Flagelin 22
|
304642-91-9
|
|
Glycoprotein (276-286)
|
Glycoprotein (276-286)
|
160543-97-5
|
|
GP(33-41)
|
GP (33-41)
|
161928-86-5
|
|
HBV Core (107-115)
|
CYS-LEU-THR-PHE-GLY-ARG-GLU-THR-VAL
|
|
|
Influenza HA (518-526)
|
ILE-TYR-SER-THR-VAL-ALA-SER-SER-LEU
|
186302-15-8
|
|
HCV, NS4A-Like Peptide
|
HCV, NS4A-LIKE PEPTIDE
|
|
|
Histatin-8 [Hemagglutination-Inhibiting Peptide (HIP)
|
HISTATIN-8
|
127637-03-0
|
|
HIV p17 Gag (77-85)
|
HIV-1 GAG PROTEIN P17 (76-84)
|
147468-65-3
|
|
HPV E7 protein (49-57)
|
HPV E7 PROTEIN (49-57)
|
|
|
HSV-1-amide UL 26 Open Reading Frame (242-255)
|
H-HIS-THR-TYR-LEU-GLN-ALA-SER-GLU-LYS-PHE-LYS-MET-TRP-GLY-NH2
|
396716-24-8
|
|
HSV-gB2 (498-505)
|
SER-SER-ILE-GLU-PHE-ALA-ARG-LEU
|
149997-91-1
|
|
Human CMV pp65 (495-503)
|
ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL
|
153045-21-7
|
|
Human Platelet Factor IV 18, C18G
|
HUMAN PLATELET FACTOR IV 18, C18G
|
|
|
CEF24, Influenza Virus PB1 Peptide (591-599)
|
CEF24, INFLUENZA VIRUS PB1 PEPTIDE (591-599)
|
|
|
TET 830 modified/T-helper epitope from tetanus toxoid
|
ALA-GLN-TYR-ILE-LYS-ALA-ASN-SER-LYS-PHE-ILE-GLY-ILE-THR-GLU-LEU
|
|
|
TfR-T12
|
转铁蛋白受体结合肽
|
344618-30-0
|
|
Thrombin Receptor Peptide Ligand, Thrombin Receptor Antagonist
|
THROMBIN RECEPTOR PEPTIDE LIGAND, THROMBIN RECEPTOR ANTAGONIST
|
|
|
TIF2 (740-753)
|
TIF2 (740-753)
|
|
|
T-NLS peptide
|
PRO-LYS-LYS-LYS-ARG-LYS-VAL-GLU-ASP-*PRO-TYR-CYS
|
105425-98-7
|
|
Transcriptional Intermediary Factor 2, Tif-2 (685-697)
|
TRANSCRIPTIONAL INTERMEDIARY FACTOR 2, TIF-2 (685-697)
|
|
|
TRAP-6 (2-6)
|
PHE-LEU-LEU-ARG-ASN
|
141136-84-7
|
|
VIP (1-12)
|
HIS-SER-ASP-ALA-VAL-PHE-THR-ASP-ASN-TYR-THR-ARG
|
120928-03-2
|
|
α-CGRP (19-37), human
|
SER-GLY-GLY-VAL-VAL-LYS-ASN-ASN-PHE-VAL-PRO-THR-ASN-VAL-GLY-SER-LYS-ALA-PHE-NH2
|
101233-12-9
|
|
H-LYS-ARG-THR-GLY-GLN-TYR-LYS-LEU-OH
|
碱性成纤维细胞生长因子(119-126)
|
152051-61-1
|
|
Adhesion factor A
|
粘合因子α
|
|
|
Calcitonin C-terminal Adjacent Peptide, rat
|
CALCITONIN C-TERMINAL ADJACENT PEPTIDE (RAT)
|
|
|
KATACALCIN
|
钙抑肽
|
85916-47-8
|
|
Val20]-HPV 16 E7 (11-19)
|
[VAL20]-HPV 16 E7 (11-19)
|
|
|
4A/4B, 5A/5B Peptide
|
AC-ASP-GLU-MET-GLU-GLU-CYS-SER-MET-SER-TYR-NH2
|
|
|
Ac-MDKVLNRE
|
AC-MDKVLNRE
|
|
|
AMPs WR
|
AMPS WR
|
|
|
Apidaecin IB
|
昆虫抗菌肽
|
123276-94-8
|
|
Aurein 1.1
|
AUREIN 1.1
|
|
|
B8R (20-27)
|
B8R (20-27)
|
|
|
Bactenecin 2A
|
BACTENECIN 2A
|
|
|
Biotinyl-KR-12 (human)
|
BIOTINYL-KR-12 (HUMAN)
|
2022956-47-2
|
|
CD36 Peptide P(139-155)
|
CYS-ASN-LEU-ALA-VAL-ALA-ALA-ALA-SER-HIS-ILE-TYR-GLN-ASN-GLN-PHE-VAL-GLN
|
|
|
CD36 Peptide P(93-110)
|
TYR-ARG-VAL-ARG-PHE-LEU-ALA-LYS-GLU-ASN-VAL-THR-GLN-ASP-ALA-GLU-ASP-ASN-CYS
|
|
|
CEF1, Influenza Matrix Protein M1 (58-66)
|
GLY-ILE-LEU-GLY-PHE-VAL-PHE-THR-LEU
|
141368-69-6
|
|
CEF10, Epstein-Barr Virus LMP2 (426-434)
|
CYS-LEU-GLY-GLY-LEU-LEU-THR-MET-VAL
|
|
|
CEF11, Epstein-Barr Virus BMLF1 (280-288)
|
CEF11, EPSTEIN-BARR VIRUS BMLF1 (280-288)
|
|
|
CEF12, Epstein-Barr Virus latent NA3B (399-408), AVF
|
CEF12, EPSTEIN-BARR VIRUS LATENT NA3B (399-408), AVF
|
|
|
CEF14, EBV Rta Protein (28-37)
|
CEF14, EBV RTA PROTEIN (28-37)
|
216862-58-7
|
|
CEF15, Epstein-Barr Virus Lytic Cycle Protein BZLF-1(190-197)
|
CEF15, EPSTEIN-BARR VIRUS LYTIC CYCLE PROTEIN BZLF-1(190-197)
|
|
|
CEF16, Epstein-Barr Virus latent NA-3A (337-347)
|
CEF16, EPSTEIN-BARR VIRUS LATENT NA-3A (337-347)
|
|
|
CEF17, Epstein-Barr Virus latent NA-3A (158-166)
|
CEF17, EPSTEIN-BARR VIRUS LATENT NA-3A (158-166)
|
|
|
CEF18, Epstein-Barr Virus latent NA-3C (258-266)
|
CEF18, EPSTEIN-BARR VIRUS LATENT NA-3C (258-266)
|
|
|
CEF19, Epstein-Barr Virus latent NA-3A (458-466)
|
L-甲硫氨酸
|
157876-41-0
|
|
CEF2, Influenza Virus PA (46-54)
|
CEF2, INFLUENZA VIRUS PA (46-54)
|
|
|
CEF21, Cytomegalovirus, CMV pp65 (417-426)
|
巨细胞病毒
|
|
|
CEF22, Cytomegalovirus, CMV pp65 (378-389)
|
CEF22, CYTOMEGALOVIRUS, CMV PP65 (378-389)
|
|
|
PLP (190-209)
|
PLP 190-209
|
|
|
PLP (56-70)
|
PLP (56-70)
|
|
|
Protease-Activated Receptor-1, PAR-1 Agonist
|
Protease-Activated Receptor-1, PAR-1 Agonist
|
|
|
Protease-Activated Receptor-1, PAR-1 Agonist, amide
|
Protease-Activated Receptor-1, PAR-1 Agonist, amide
|
|
|
PrP (106-114)
|
PRP (106-114)
|
|
|
PrP (127-147)
|
PRP (127-147)
|
|
|
PrP (57-64)
|
PRP (57-64)
|
|
|
PrP (89-106)
|
PRP (89-106)
|
|
|
Scyliorhinin I
|
ALA-LYS-PHE-ASP-LYS-PHE-TYR-GLY-LEU-MET-NH2
|
103425-21-4
|
|
SmMLCKp, Smooth-Muscle Myosin Light-Chain Kinase (796-815), Calmodulin Binding
|
SMMLCKP, SMOOTH-MUSCLE MYOSIN LIGHT-CHAIN KINASE (796-815), CALMODULIN BINDING
|
|
|
Soymetide-4, MITL
|
SOYMETIDE-4, MITL
|
|
|
Steroid Receptor Coactivator-1, SRC-1 (686-700)
|
STEROID RECEPTOR COACTIVATOR-1, SRC-1 (686-700)
|
|
|
Steroid Receptor Co-Factor Peptide
|
LEU-THR-GLU-ARG-HIS-LYS-ILE-LEU-HIS-ARG-LEU-LEU-GLN-GLU
|
|
|
Substance P (8-11)
|
SUBSTANCE P (8-11)
|
|
|
SynB1
|
SYNB1
|
|
|
Tau-Protein (1-16)
|
TAU-PROTEIN (1-16)
|
|
|
Tau-Protein (323-335)
|
TAU-PROTEIN (323-335)
|
|